Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222
Blood (2005) 105 (9): 3420–3427.
Currently there are no citedby results. Try again later.
